Key result
Higher nighttime SBP is linked to ~53% higher CV mortality per SD in peritoneal dialysis.
Why the study?
The association between ambulatory blood pressure measurements, specifically nighttime systolic blood pressure, and survival outcomes in peritoneal dialysis patients remains uncertain.
Does elevated nighttime systolic blood pressure increase the risk of cardiovascular and all-cause mortality in patients receiving peritoneal dialysis?
Cohort (n=165)
No
Does elevated nighttime systolic blood pressure increase the risk of cardiovascular and all-cause mortality in patients receiving peritoneal dialysis?
Hazard Ratio: 1.53 (95% CI 1.05–2.21)
p-value: p=0.026
Elevated nighttime systolic blood pressure, frequently missed by office measurements, is a significant and independent predictor of cardiovascular and all-cause mortality in peritoneal dialysis patients.
Nighttime SBP may aid risk stratification in peritoneal dialysis; hypothesis-generating for interventional trials.
Background/Objectives: The link between ambulatory-blood-pressure-derived measurements and survival outcomes among patients receiving peritoneal dialysis (PD) remains uncertain. This study sought to explore whether nighttime systolic blood pressure (SBP) obtained from 24-h ambulatory blood pressure monitoring (ABPM) is associated with cardiovascular (CV) and all-cause mortality in PD individuals. Methods: Between 1 January 2017 and 30 June 2021, this single-center sub-cohort study (derived from a prospective database of PD) enrolled 165 PD participants with a median follow-up of 47.4 months from the date of ABPM completion. Competing risk regression was applied to estimate the association between nighttime SBP and CV mortality, accounting for competing death events. Multivariable Cox proportional hazards regression was utilized to quantify nighttime SBP’s independent correlation with all-cause mortality. Results: Over the follow-up period, 48 patients (29.1%) died, with 28 (58.3%) cases attributed to CV causes. In the fully adjusted model, each 1 SD rise in nighttime SBP corresponded to a subdistribution hazard ratio (SHR) of 1.53 (95% confidence interval [CI], 1.05–2.21; p = 0.026) for CV mortality. In the Cox regression model, every 1 SD increase in nighttime SBP showed an independent association with a 42% excess risk of all-cause mortality (hazard ratio [HR] = 1.42, 95% CI, 1.04–1.93; p = 0.026). Quartile-stratified analyses indicated that participants within the uppermost nighttime SBP quartile exhibited higher mortality risk for both endpoints compared to those in the lowest quartile. Conclusions: Elevated nighttime SBP is associated with increased CV and all-cause mortality risk in PD patients.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2026) conducted a cohort in End-stage renal disease on peritoneal dialysis (n=165). Elevated nighttime systolic blood pressure vs. Lower nighttime systolic blood pressure was evaluated on Cardiovascular mortality (SHR 1.53, 95% CI 1.05-2.21, p=0.026). Each 1 SD increase in nighttime systolic blood pressure was associated with a 53% increased risk of cardiovascular mortality (SHR 1.53, 95% CI 1.05-2.21, p=0.026) in patients receiving peritoneal dialysis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: